ProfileGDS5678 / 1455269_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 99% 98% 99% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.455398
GSM967853U87-EV human glioblastoma xenograft - Control 210.875499
GSM967854U87-EV human glioblastoma xenograft - Control 310.383498
GSM967855U87-EV human glioblastoma xenograft - Control 411.034999
GSM967856U87-EV human glioblastoma xenograft - Control 510.672298
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.388298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.318598
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.464198
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.262198
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.9657398
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.9361598
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.097298
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.148898
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.152898